The Michael J. Fox Foundation works tirelessly to accelerate promising research toward breakthroughs for Parkinson's patients. While our strong emphasis is on funding translational and clinical research, we also support high-risk/high-reward discovery work.
Deadlines April 19, 2019
- Applied Technologies as Treatments for Parkinson's
- Assay Development and Validation for Quantifying Oligomeric Alpha-Synuclein
- Biology of Astrocytes in Parkinson’s Disease
- Imaging Biomarkers to Track Disease Progression and Therapeutic Efficacy
Parkinson's Disease Therapeutic Development Pipeline Program
Pre-proposals due April 19, 2019